Dafalgan, Brausetabletten 500 mg - 16 Tablette(n) Swissmedic Key 47503027 Registration Holder UPSA Switzerland AG Name Dafalgan, Brausetabletten 500 mg Date of registration 03.12.1986 Introduction of Sequence 03.12.1986 ATC-Classification Paracetamol (N02BE01) Revision date 12.01.2006 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.01.10. Show package size 16 Tablette(n) Index Therapeuticus (Swissmedic) 01.01.10. Description Swissmedic categorie. D SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1.46 Limitation No Deductible 10 % Consumer price 2.70 Feedback FB Daily cost GTIN 7680475030271 Medication Code Synthetika Pharmacode 1336653 Disponibility
Composition paracetamolum 500 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, natrii docusas, povidonum, sorbitolum 300 mg, saccharinum natricum, E 211 60.606 mg pro compresso corresp. natrium 412.3 mg. Teilbarkeit Teilbar Nein Auflösbar oder suspendierbar Ja Zermörsebar Ja Öffnen von Kapseln -- Bemerkungen / Alternativen Quellen
th_part Active Agent Dose Paracetamol 500 mg
BAG: Active Agent Dose Paracetamol 500 mg
Inactive agents Dose additional_information Citric Acid E 211 60.606 mg conserv. Sodium Carbonate Natrii Docusas Sodium Hydrogen Carbonate Povidone Pro Compresso Saccharinum Natricum Sorbitol 300 mg
Source Data was imported : 06.07.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
